Patents by Inventor Emmanuelle Charafe-Jauffret

Emmanuelle Charafe-Jauffret has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIOMARKERS FOR THE IDENTIFICATION OF CHEMOSENSITIVITY
    Publication number: 20160040251
    Abstract: The instant application provides biomarkers for the identification of chemosensitivity in patient having cancer, in a particular embodiment the invention provides MST for the identification of chemosensitivity in breast cancer patient, wherein a reduced expression of XIST in the breast cancer cells of the patient indicates that the breast cancer stem cells in the patient may be successfully treated with HDAC inhibitor.
    Type: Application
    Filed: April 4, 2014
    Publication date: February 11, 2016
    Applicant: PHARMACYCLICS, LLC
    Inventors: Daniel BIRNBAUM, Emmanuelle CHARAFE-JAUFFRET, Christophe GINESTIER, Marion SALVADOR
  • Aldehyde dehydrogenase 1 (ALDH1) as a cancer stem cell marker
    Patent number: 8435746
    Abstract: The present invention relates to compositions and methods for treating, characterizing, and diagnosing cancer. In particular, the present invention provides a novel stem cell cancer marker, ALDH1, useful for the diagnosis, characterization, and treatment of solid tumor stem cells.
    Type: Grant
    Filed: July 6, 2010
    Date of Patent: May 7, 2013
    Assignee: The Regents of the University of Michigan
    Inventors: Max S. Wicha, Gabriela Dontu, Christophe Ginestier, Emmanuelle Charafe-Jauffret, Suling Liu
  • Aldehyde Dehydrogenase 1 (ALDH1) as a Cancer Stem Cell Marker
    Publication number: 20100291581
    Abstract: The present invention relates to compositions and methods for treating, characterizing, and diagnosing cancer. In particular, the present invention provides a novel stem cell cancer marker, ALDH1, useful for the diagnosis, characterization, and treatment of solid tumor stem cells.
    Type: Application
    Filed: July 6, 2010
    Publication date: November 18, 2010
    Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Max S. Wicha, Gabriela Dontu, Christophe Ginestier, Emmanuelle Charafe-Jauffret, Suling Liu
  • ALDH1 As A Cancer Stem Cell Marker
    Publication number: 20080187938
    Abstract: The present invention relates to compositions and methods for treating, characterizing, and diagnosing cancer. In particular, the present invention provides a novel stem cell cancer marker, ALDH1, useful for the diagnosis, characterization, and treatment of solid tumor stem cells.
    Type: Application
    Filed: September 24, 2007
    Publication date: August 7, 2008
    Applicant: The Regents of the University of Michigan
    Inventors: Max S. Wicha, Gabriela Dontu, Christophe Ginestier, Emmanuelle Charafe-Jauffret, Suling Liu